POLYVALENT MELANOMA VACCINE IMPROVES SURVIVAL OF PATIENTS WITH METASTATIC MELANOMA

被引：0
|
作者：
MORTON, DL [1 ]
HOON, DSB [1 ]
NIZZE, JA [1 ]
FOSHAG, LJ [1 ]
FAMATIGA, E [1 ]
WANEK, LA [1 ]
CHANG, C [1 ]
IRIE, RF [1 ]
GUPTA, RK [1 ]
ELASHOFF, R [1 ]
机构：
[1] ST JOHNS HOSP, SANTA MONICA, CA 90404 USA
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1993年 / 690卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：120 / 134
页数：15
相关论文
共 50 条
  • [31] Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma.
    Bystryn, JC
    Oratz, R
    Shapiro, R
    Harris, M
    Roses, D
    Jacquotte, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 498 - 498
  • [32] LARGE MULTIVALENT IMMUNOGEN VACCINE IN PATIENTS WITH METASTATIC MELANOMA
    Dudek, Arkadiusz Z.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3270 - 3271
  • [33] DEVELOPMENT OF A POLYVALENT MELANOMA TUMOR-ANTIGEN VACCINE
    BYSTRYN, JC
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1983, 9 (08): : 648 - 649
  • [34] PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTRYN, JC
    LEVIN, M
    SPEYER, S
    HARRIS, M
    ROSES, D
    BERNSTEIN, P
    CLINICAL RESEARCH, 1984, 32 (02): : A574 - A574
  • [35] PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTTRYN, JC
    LEVIN, M
    SPEYER, S
    HARRIS, M
    ROSES, D
    BERNSTEIN, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (04) : 425 - 426
  • [36] Ipilimumab attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma
    Peggs, Karl S.
    Quezada, Sergio A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (11) : 1697 - 1701
  • [37] SURVIVAL IN METASTATIC OCULAR MELANOMA
    RAJPAL, S
    MOORE, R
    KARAKOUSIS, CP
    CANCER, 1983, 52 (02) : 334 - 336
  • [38] LONG SURVIVAL IN METASTATIC MELANOMA
    TOLINS, S
    ARCHIVES OF SURGERY, 1973, 107 (03) : 942 - 942
  • [39] Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): Correlation with survival
    Eddy C. Hsueh
    Estela Famatiga
    Rishab K. Gupta
    Karen Qi
    Donald L. Morton
    Annals of Surgical Oncology, 1998, 5 : 595 - 602
  • [40] Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): Correlation with survival
    Hsueh, EC
    Famatiga, E
    Gupta, RK
    Qi, K
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (07) : 595 - 602
12345